Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

Patent 10435392 was granted and assigned to Incyte on October, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Incyte
Incyte
0
Date Filed
February 15, 2018
0
Date of Patent
October 8, 2019
0
Patent Applicant
Incyte
Incyte
0
Patent Application Number
15897598
0
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
‌
US Patent 11685731 Processes of preparing a JAK1 inhibitor
0
‌
US Patent 11304949 Treatment of hidradenitis suppurativa using JAK inhibitors
‌
US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders
0
‌
US Patent 11905275 Bipyrazole derivatives as JAK inhibitors
0
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
‌
US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo
0
‌
US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
0
‌
US Patent 11001571 Bipyrazole derivatives as JAK inhibitors
0
‌
US Patent 11591318 Bipyrazole derivatives as JAK inhibitors
0
Patent Inventor Names
Song Mei
0
Jincong Zhuo
0
Yun-Long Li
0
Ding-Quan Qian
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10435392
0
Patent Primary Examiner
‌
Kamal A Saeed
0

Find more entities like US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo